Excelra Blog

Data Science To Empower
Life Science Innovation

Latest Stories

Excelra

Featured Stories

Posts by Excelra

Repurposed Drugs for COVI...

Drug repurposing or repositioning is a promising approach for identifying new indications ...

GOBIOM Updates | July 202...

GOBIOM is built from exploratory, preclinical and clinical content to provide critical ins...

Biopharma Industry Update...

Biomarkers Apelin-13 Apelin-13, a 13 amino acid oligopeptide which is the ligand for the a...

FAIRification: A Path to ...

Genesis of the concept of FAIRification

Empowering Drug Discovery...

Any data that requires support from technological and infrastructural investments in order...

Omics data management & a...

OMICS has paved the way for incredible advances in the various fields of clinical, medical...

GOBIOM Updates | March 20...

Excelra's GOBIOM is a comprehensive biomarker database comprising exploratory, preclinical...

Biopharma Industry Update...

Biomarkers Serum soluble ST2 Protein implicated in the progression of cardiac disease is a...

Drug Approvals in 2020

In 2020, despite several challenges due to the COVID-19 pandemic, the FDA has approved man...

GOSTAR Updates in 2020

GOSTAR is the largest manually annotated structure-activity relationship (SAR) database of...

Subscribe for Updates

Flagship Products

GOSTAR-Home-new

 

GOBIOM-Home-new

 

Resources

Request Meeting

Social Wall

Lorem Ipsum is a simple dummy text used as a dummy text contents. Lorem ipsum will be replaced. Lorem Ipsum is a simple dummy text used as a dummy text contents. Lorem ipsum will be replaced.Lorem Ipsum is a simple dummy text used as a dummy text contents. Lorem ipsum will be replaced.
BUY On HUBSPOT